Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of MYCL will - over the next 2 Weeks and hit - by . In that time frame, MYCL's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
MYCL shares fell -0.16% in Friday, September 11, 2026's trading session, dropping from a previous close of $23.92 to move at $23.88. The stock demonstrated notable intraday movement (see MYCL's key stats for a full breakdown), fluctuating between $23.88 and $23.95, a +0.29% trading range. While recent weeks have seen some volatility, MYCL has managed to secure a -1.72% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 532 shares changing hands, 496 more than the previous session. This amounted to $12.70K in total market activity.
Will MYCL Continue Its Trend?
According to analyst ratings and projections for MYCL, State Street My2032 Corporate Bond ETF shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators for MYCL currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 19 negative trading days within the past 30 sessions. Based on the MYCL stock forecast, now is not the best time to buy MYCL stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on MYCL covering social and institutional perspectives.
MYCL Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into MYCL's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 17.83% to 29.24%) suggest the stock is in a strong bearish momentum phase. The 50-day RSI, at 38.41%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 42.92%, maintains a neutral outlook for the long term. Insights into MYCL's shareholder base show how institutional investors are positioning themselves during these momentum shifts

